cGAS inhibition decreases ISG RNA in H358 cells. by Lorellin A. Durnell-Bettis (22656332)

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Subjects:

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Subjects:

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Co-Contraction index of right and left gluteus medius activity (MVC%) during 60 minutes standing (time- condition) between two groups (A: used the footrest intermittently, B: used... by Saeedeh Abbasi (9423189)

A. Cost-effectiveness plane for the base case with QALY as outcome measure. by Ruben M.W.A. Drost (21647598)

Subjects:

A. Cost-effectiveness plane for the base case with GARS-4 as outcome measure. by Ruben M.W.A. Drost (21647598)

Subjects:

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

BrdU incorporation is elevated in clrn1-/- zebrafish at 4 mpf and decreases with age. by Hannah J. T. Nonarath (20861735)

“…<p>Anti-BrdU (green) staining in paraffin sections from (a,a’) 4 mpf, (b,b’) 8 mpf, (c,c’) 12 mpf, and (d,d’) 20 mpf in wild-type and <i>clrn1</i>^<i>-/-</i> zebrafish retinas. …”

Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

Subjects:

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

Subjects:

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Subjects:

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Mean per-participant costs by condition at baseline based on a 3-month recall period (€, indexed for 2022). Data are presented as mean (standard deviation). The cost prices utilize... by Ruben M.W.A. Drost (21647598)

Subjects:

Odds of being underweight (A), overweight (B) or obese (C) according to restricted cubic splines (RCSs) regression. by Sheikh Arafat Rahman (21799685)

Subjects:

Details of endotracheal intubation management in the control and intervention arms by Hugo Hille (11294179)

Correlations between the MUAC and BMI (A.) and receiver operating characteristic curve for mid-upper arm circumference (MUAC) for the detection of individuals with underweight, ove... by Sheikh Arafat Rahman (21799685)

Subjects:

Minimal anonymised dataset SELF study - RAW data - English. by Ruben M.W.A. Drost (21647598)

Subjects: